Diagnos Laboratorium Utama Tbk. vs Ingria Pratama Capitalindo Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Ingria Pratama Capitalindo Tbk. trades at Rp110 (market cap 811.33B, 10.51M 24h volume). The key difference: Ingria Pratama Capitalindo Tbk. is far larger — about 2.6× Diagnos Laboratorium Utama Tbk.'s market cap, and Ingria Pratama Capitalindo Tbk. is more actively traded (10.51M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | GRIA | |
|---|---|---|
Market Cap | 310.75B | 811.33B |
Volume | 963.6K | 10.51M |
Lot | 9.64K | 105.06K |
Turnover | 217.67M | 1.19B |
Average Price | 225.89 | 113.06 |
Value | 217.67M | 1.19B |
Indicative Equilibrium Price | 226 | 110 |
Indicative Equilibrium Volume | 1K | 745 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Ingria Pratama Capitalindo Tbk (the “Company”) was established based on Notarial Deed No. 04 dated 8 May 2013 of Euis Widari, S.H. The Company commenced its operationalactivity with purchases of land in 2017.
Read more on GRIA →